Table 2

Bacteriologically confirmed recurrence, total number of recurrences and time to first recurrence between HA+CS versus standard of care treated patients

OutcomeOR (95% CI)Adjusted* OR (95% CI)
Bacteriologically confirmed recurrence0.77 (0.46 to 1.28)0.51 (0.27 to 0.96)
IRR (95% CI)Adjusted* IRR (95% CI)
Total number of bacteriologically confirmed recurrence1.73 (1.27 to 2.37)0.99 (0.69 to 1.43)
HR (95% CI)Adjusted* HR (95% CI)
Time to first bacteriologically confirmed recurrence1.66 (1.09 to 2.54)†0.99 (0.61 to 1.61)
  • *Adjusted for age, BMI, employment and menopause status, postcoital infections, dyspareunia, FSFI and severity of RUTI.

  • †Log-rank test p value 0.018.

  • BMI, body mass index; FSFI, Female Sexual Function Index; HA+CS, hyaluronic acid and chondroitin sulfate; IRR, incidence rate ratio; RUTI, recurrent urinary tract infection.